| Literature DB >> 33815696 |
Rahul Dev1, Khorwal Gitanjali2, Darbari Anshuman3.
Abstract
This review article describes demographic features, comorbidities, clinical and imaging findings, prognosis, and treatment strategies in penetrating atherosclerotic ulcer (PAU) and closely related entities using google scholar web search. PAU is one of the manifestations of the acute aortic syndrome (AAS) spectrum. The underlying aorta invariably shows atherosclerotic changes or aneurysmal dilatation. Hypertension is the most common contributing factor, with chest or back pain being the usual manifestation. Intramural hematoma (IMH) is the second entity associated with both PAU and aortic dissection (AD), more so with the latter. Chest radiograph can show mediastinal widening, pleural, or pericardial fluid in rupture. Computed tomography angiography (CTA) is the imaging modality of choice to visualize PAU, with magnetic resonance imaging (MRI) and transoesophageal echocardiography (TEE) adding diagnostic value. Lesser-known entities of intramural blood pool (IBP), limited intimal tears (LITs), and focal intimal disruptions (FID) are also encountered. PAU can form fistulous communication with adjacent organs whereas IMH may propagate to dissection. CTA aids in defining the management, open or endovascular options in surgical candidates.Entities:
Keywords: Aortic Dissection; Computed Tomography Angiography; Intramural Hematoma; Penetrating Atherosclerotic Ulcer; Thoracic Endovascular Aortic Repair
Year: 2021 PMID: 33815696 PMCID: PMC8007901 DOI: 10.34172/jcvtr.2021.15
Source DB: PubMed Journal: J Cardiovasc Thorac Res ISSN: 2008-5117
General profile
|
|
|
|
|
|
|
|
|
|
|
|
|
Stanson et al[ | 1986 | 16 | 74+10 | 8:8 | HTN, CAD, Hyperlipidemia | 11 (68) –Smoking | 13 (81) | 3 – TAA | 13 (81) |
4 – postoperative paraplegia |
|
Kazerooni et al[ | 1992 | 16 | 73+15 | 7:9 | HTN, CAD, PVD, CVA | ----- | 13 (81) | 6 – Aneurysm | 1 (6) | 1 – perioperative CVA |
|
Harris et al[ | 1994 | 18 | 74+12 | 10:8 |
HTN, CAD, | ----- | 4 (22) | 12 - Aneurysm | 0 (0) |
2 – distal foot ischemia |
|
Coady et al[ | 1998 | 19 | 74+11 | 9:10 | HTN, CAD, COPD, CKD, DM | ----- | 16 (84) | 8 – AAA | 8 (44) | ----- |
|
Vilacosta et al[ | 1998 | 12 | 65+10 | 12:0 | HTN, CAD, Hyperlipidemia |
10 (83) – | 12 (100) | 2 – TAA | 6 (50) |
2 – syncope |
|
Hayashi et al[ | 2000 | 12 | 70+5 | 11:1 | ----- | ----- | 6 (50) |
2 – TAA | 2 (16) | 1 – died of unrelated disease |
|
Quint et al[ | 2001 | 38 | 75+20 | 20:18 | ----- | ----- | 22 (58) | ----- | 2 (5) |
1 – AKD |
|
Ganaha et al[ | 2002 | 65 | 69+10 | 34:31 | HTN | ----- | 63 |
10 – TAA | 663 (91) |
1 – hemoptysis |
|
Tittle et al[ | 2002 | 45 | 71+17 | 18:27 | ----- | ----- | 45 (100) | ----- | 34 (75) |
2 – unspecific non-cardiovascular cause |
|
Cho et al[ | 2004 | 105 | 72+9 | 73:32 | HTN, COPD, CKD, CAD |
81 (77) – | 79 (75) | 64 – AAA | 9 (9) |
1 – mycotic involvement |
|
Batt et al[ | 2004 | 8 | 72+6 | 7:1 | HTN, COPD, CAD, CVA, PVD, DM |
8 (100) – | 6 (75) |
1 – TAA | 3 (37) |
4 – SAP |
|
Piffaretti et al[ | 2006 | 13 | 73+7 | 12:1 | HTN, DM, COPD, CAD, CKD, Hyperlipidaemia | ----- | 10 (76) | ----- | ----- |
5 – thrombus in AA |
|
Brinster et al[ | 2006 | 21 | 73+12 | 7:14 | HTN, DM, COPD, CAD, CKD, CHF, Hyperlipidaemia |
16 (76) – | 16 (76) | ----- | 4 (19) |
4 – previous CVA |
|
Piffaretti et al[ | 2007 | 11 | 68+13 | 9:2 | HTN, COPD, CKD, IHD | ----- | 6 (54) |
3 – concomitant AAA | 4 (36) |
3 – acute renal failure |
|
Kuehl et al[ | 2008 | 33 | 66+20 | 28:5 | HTN, CAD, DM | ----- | ----- | 5 – TAA | 14 (42) | ----- |
|
Patel et al[ | 2010 | 37 | 72+10 | 16:21 | HTN, COPD, CAD, CVA, PVD, DM | 20 (54) –Smoking | 36 (97) | 1 – TAA | 15 (40) |
2 – perioperative stroke |
|
Nathan et al[ | 2012 | 315 | 70+10 | 234:81 | HTN, COPD, DM, CAD, Hyperlipidaemia, CKD | ----- | 69 (21) | 288 – TAA/ AAA | 16 (0.05) | ----- |
|
Patel et al[ | 2012 | 95 | 70+9 | 44:51 | HTN, CAD, PVD, DM |
Smoking – | ----- | 24 – repaired AAA | 34 (35) | 8 – infected aortic pathology |
|
Salim et al[ | 2019 | 43 | 66+25 | 26:17 | HTN, COPD, DM, CKD, IHD |
Smoking – | 16 (37) | ----- | ----- | 11 – aortic surgery for non-PAU disease |
Abbreviations: HTN, hypertension; CAD, coronary artery disease; TAA, thoracic aortic aneurysm; CVA, cerebrovascular accident; PVD, peripheral vascular disease; DM, diabetes mellitus; CKD, chronic kidney disease; SAP, subadventitial pseudoaneurysm; SMA, superior mesenteric artery; DVT, deep vein thrombosis; COPD, chronic obstructive pulmonary disease; AAA, abdominal aortic aneurysm; MI, myocardial infarction; AKD, acute kidney disease; CLD, chronic liver disease; IHD, ischaemic heart disease; CIAA, common iliac artery aneurysm; PAA, popliteal artery aneurysm; IMA, inferior mesenteric artery; CHF, congestive heart failure
Figure 1
Figure 2
Figure 3Imaging findings
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
| |||||
|
Stanson et al[ | 1986 | 16 | ----- | 16 (100) | 1:1:14 | 5 (31) | 15 (93) | 2:14 | 20 | 8 (50) | 1 (6) |
|
Kazerooni et al[ | 1992 | 16 | ----- | 16 (100) | 0:1:15 | 1 (6) | 16 (100) | ----- | ----- | ----- | 7 (43) |
|
Harris et al[ | 1994 | 18 | ----- | 18 (100) | 0:1:18 | 11 (61) | ----- | ----- | ----- | ----- | 3 (16) |
|
Coady et al[ | 1998 | 212 | 62+15 | 19 (9) | 2:2:17 | ----- | 17 (8) | 5:12 | ----- | ----- | ----- |
|
Vilacosta et al[ | 1998 | 12 | ----- | 12 (100) | 1:2:3 | 1 (8) | 1 (8) | ----- | ----- | ----- | ----- |
|
Hayashi et al[ | 2000 | 12 | ----- | 12 (100) | 0:0:12 | 12 (100) | ----- | ----- | ----- | ----- | ----- |
|
Quint et al[ | 2001 | 38 | 51 | 38 (100) | 1:14:35 | 1 (2.6) | 22 (58) | ----- | ----- | ----- | 5 (13) |
|
Ganaha et al[ | 2002 | 65 | 47.4+8.3 | 34 (9) | ----- | ----- | 65 (100) | 28:37 | ----- | ----- | 20 (30) |
|
Tittle et al[ | 2002 | 45 | 59 | 26 (57) | 12:0:14 | ----- | 19 (42) | 11:8 | ----- | ----- | ----- |
|
Cho et al[ | 2004 | 105 | 43.4+7.9 | 105 (100) | 0:9:99 | 11 (10) | 85 (81) | 22:83 | 9.7+4.0 | 49 (58) | 32 (30) |
|
Batt et al[ | 2004 | 8 | ----- | 8 (100) | 8 – AA | ----- | ----- | ----- | ----- | ----- | ----- |
| Piffaretti et al82 | 2006 | 13 | ----- | 13 (100) | 13 – AA | ----- | ----- | ----- | ----- | ----- | ----- |
|
Brinster et al[ | 2006 | 21 | ----- | 21 (100) | ----- | ----- | ----- | ----- | ----- | ----- | ----- |
|
Piffaretti et al[ | 2007 | 11 | 60 | 9 (81) | 0:5:4 | ----- | ----- | ----- | ----- | ----- | 2 (18) |
|
Kuehl et al[ | 2008 | 33 | ----- | 8 (24) | ----- | ----- | 6 (18) | ----- | ----- | ----- | ----- |
|
Patel et al[ | 2010 | 37 | 50+14 | 37 (100) | ----- | ----- | 19 (51) | ----- | ----- | ----- | ----- |
|
Nathan et al[ | 2012 | 315 | 315 (100) | 0:28:240 | 73 (23) | 56 (17) | ----- | ----- | ----- | ----- | |
|
Patel et al[ | 2012 | 95 | 58+15 | 95 (100) | ----- | ----- | 41 (43) | ----- | ----- | ----- | ----- |
|
Salim et al[ | 2019 | 43 | 35.6+8.6 | 43 (100) | 0:11:32 | 9 (20) | ----- | ----- | ----- | ----- | ----- |
Abbreviations: PAU, penetrating atherosclerotic ulcer; IMH, intramural hematoma; Ar, arch; As, ascending;